Orchid Pharma consolidated net profit rises 212.23% in the June 2024 quarter

Net profit of Orchid Pharma rose 212.23% to Rs 29.35 crore in the quarter ended June 2024 as against Rs 9.40 crore during the previous quarter ended June 2023. Sales rose 33.62% to Rs 244.41 crore in the quarter ended June 2024 as against Rs 182.92 crore during the previous quarter ended June 2023.

Particulars	Quarter Ended
	Jun. 2024	Jun. 2023	% Var.
Sales	244.41	182.92	34
OPM %	13.29	12.10	-
PBDT	36.56	18.48	98
PBT	28.12	10.78	161
NP	29.35	9.40	212